Role of metabolic reprogramming in pro-inflammatory cytokine secretion from LPS or silica-activated macrophages

A Marrocco, LA Ortiz - Frontiers in immunology, 2022 - frontiersin.org
In the lungs, macrophages constitute the first line of defense against pathogens and foreign
bodies and play a fundamental role in maintaining tissue homeostasis. Activated …

Understanding the pathogenesis of occupational coal and silica dust-associated lung disease

KS Vanka, S Shukla, HM Gomez… - European …, 2022 - Eur Respiratory Soc
Workers in the mining and construction industries are at increased risk of respiratory and
other diseases as a result of being exposed to harmful levels of airborne particulate matter …

Gefitinib and fostamatinib target EGFR and SYK to attenuate silicosis: a multi-omics study with drug exploration

M Wang, Z Zhang, J Liu, M Song, T Zhang… - … and Targeted Therapy, 2022 - nature.com
Silicosis is the most prevalent and fatal occupational disease with no effective therapeutics,
and currently used drugs cannot reverse the disease progress. Worse still, there are still …

Pulmonary toxicity of silica linked to its micro-or nanometric particle size and crystal structure: A review

V Marques Da Silva, M Benjdir, P Montagne, JC Pairon… - Nanomaterials, 2022 - mdpi.com
Silicon dioxide (SiO2) is a mineral compound present in the Earth's crust in two mineral
forms: crystalline and amorphous. Based on epidemiological and/or biological evidence, the …

[HTML][HTML] Pirfenidone ameliorates pulmonary inflammation and fibrosis in a rat silicosis model by inhibiting macrophage polarization and JAK2/STAT3 signaling …

Q Tang, C Xing, M Li, Q Jia, C Bo, Z Zhang - … and environmental safety, 2022 - Elsevier
Macrophages play an important role in causing silicosis eventually becoming an irreversible
fibrotic disease, and there are no specific drugs for silicosis in the clinic so far. Pirfenidone …

[HTML][HTML] A novel pathophysiological classification of silicosis models provides some new insights into the progression of the disease

Z Cao, M Song, Y Liu, J Pang, Z Li, X Qi, T Shu… - Ecotoxicology and …, 2020 - Elsevier
Silicosis is caused by massive inhalation of silica-based particles, which leads to pulmonary
inflammation, pulmonary fibrosis and lung dysfunction. Currently, the pathophysiological …

[HTML][HTML] PD-1/PD-L1 inhibitor ameliorates silica-induced pulmonary fibrosis by maintaining systemic immune homeostasis

Y Zhao, C Hao, M Li, Y Qu, Y Guo, X Deng, H Si… - Biomedicine & …, 2022 - Elsevier
Pulmonary fibrosis induced by silica particles is defined as silicosis, which is an incurable
disease. The pathogenesis of silicosis is not completely clear, but it's certain that immune …

Macrophage-targeted lung delivery of dexamethasone improves pulmonary fibrosis therapy via regulating the immune microenvironment

X Sang, Y Wang, Z Xue, D Qi, G Fan, F Tian… - Frontiers in …, 2021 - frontiersin.org
Idiopathic pulmonary fibrosis (IPF) is serious chronic lung disease with limited therapeutic
approaches. Inflammation and immune disorders are considered as the main factors in the …

[HTML][HTML] Immunomodulatory and antiviral effects of Lycium barbarum glycopeptide on influenza a virus infection

R Li, S Qu, M Qin, L Huang, Y Huang, Y Du, Z Yu… - Microbial …, 2023 - Elsevier
Influenza is caused by a respiratory virus and has a major global impact on human health.
Influenza A viruses in particular are highly pathogenic to humans and have caused multiple …

Crystalline silica-induced proinflammatory interstitial macrophage recruitment through notch3 signaling promotes the pathogenesis of silicosis

H Yuan, Y You, Y He, Y Wei, Y Zhang… - Environmental …, 2023 - ACS Publications
Crystalline silica (CS) particles are ubiquitous in the environment, especially in occupational
conditions, and exposure to respirable CS causes silicosis. The initial response to CS is …